INJECTABLE FORMULATIONS OF CHROMIUM III FOR FORTIFYING THE IMMUNE RESPONSE IN DOMESTIC ANIMALS FOR PRODUCTION

The present invention is related to an injectable formulation based in chromium III, which are prepared as emulsions containing a-tocopherol in a concentration ranging from about 1 to about 200 UI/ml, chromium picolinate in a concentration raging from about 0.01 to about 0.5 mg/ml and casein peptone...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ENRIQUE CRUZ OLMOS, FRANCISCO GONZALEZ SOUZA
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention is related to an injectable formulation based in chromium III, which are prepared as emulsions containing a-tocopherol in a concentration ranging from about 1 to about 200 UI/ml, chromium picolinate in a concentration raging from about 0.01 to about 0.5 mg/ml and casein peptone in a concentration raging from about 0.1 to about 100 mg/ml. The invention also refers to the use of said emulsion along with an injectable formulation that contains selenium, which are administered in a simultaneous or dissimilar manner in an administration scheme that allows the immune system in domestic animals for production, either healthy or in a sub clinical disease condition, to be improved. La presente invención reclama formulaciones inyectables a base de cromo III que se preparan como emulsiones que contienen a-tocoferol en un intervalo de concentración de 1 a 200 UI/ml, picolinato de cromo en un intervalo de concentración de 0.01 a 0.5 mg/ml y peptona de caseína en un intervalo de concentración de 0.1 mg/ml a 100 mg/ml. También se refiere al uso de dicha emulsión en combinación con una formulación inyectable que contiene selenio, administradas de manera simultánea o disímil en un esquema de administración que permite mejorar el sistema inmunológico de animales domésticos para producción sanos o en estados de enfermedad subclínica.